Yasutaka Yamamoto Selected Research

Yasutaka Yamamoto Research Topics

Disease

6	Ischemia 01/2018 - 11/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2013 - 09/2003
3	Heart Failure 01/2022 - 09/2002
3	Myocardial Infarction 01/2022 - 01/2015
3	Proteinuria 01/2018 - 06/2007
3	Glomerulonephritis 01/2016 - 01/2013
3	Hypertension (High Blood Pressure) 05/2011 - 09/2002
3	Diabetes Mellitus 06/2007 - 09/2002
2	Acute Kidney Injury (Acute Renal Failure) 11/2022 - 01/2014
2	Hypoxia (Hypoxemia) 01/2022 - 08/2016
2	Fibrosis (Cirrhosis) 01/2018 - 08/2016
2	Insulin Resistance 09/2016 - 03/2007
2	Long QT Syndrome 07/2014 - 02/2011
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2011 - 12/2008
2	Pain (Aches) 02/2010 - 11/2008
2	Ulcer 11/2008 - 07/2006
2	Chronic Limb-Threatening Ischemia 11/2008 - 07/2006
2	Atherosclerosis 11/2006 - 09/2003
1	Anuria 11/2022
1	Hematoma 11/2022
1	Hemorrhage 11/2022
1	Chronic Renal Insufficiency 01/2018
1	Left Ventricular Dysfunction 01/2018
1	Body Weight (Weight, Body) 09/2016
1	Obesity 09/2016
1	Non-alcoholic Fatty Liver Disease 09/2016
1	Cicatrix (Scar) 08/2016
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2016
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2016
1	Nephritis 01/2016
1	Hematuria 01/2016
1	Juvenile gout 08/2015
1	Albuminuria 08/2015
1	Essential Hypertension 01/2014
1	Hyperglycemia 01/2014
1	Long Qt Syndrome 2 12/2013
1	Cardiac Arrhythmias (Arrythmia) 11/2011
1	Graves Disease (Basedow Disease) 02/2009
1	Thyroid Diseases (Thyroid Disease) 02/2009
1	Thyroiditis 02/2009
1	Thromboangiitis Obliterans (Buerger's Disease) 11/2008

Drug/Important Bio-Agent (IBA)

4	Uric Acid (Urate)IBA 08/2015 - 11/2006
3	purineIBA 08/2015 - 09/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 09/2016
2	Conditioned Culture MediaIBA 01/2022 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2014
2	FYX-051IBA 01/2018 - 08/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2014
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2016 - 02/2010
2	Therapeutic UsesIBA 01/2016 - 01/2013
2	AntigensIBA 01/2016 - 01/2016
2	Xanthine OxidaseIBA 08/2015 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 12/2013 - 12/2008
2	Carrier Proteins (Binding Protein)IBA 11/2011 - 12/2008
2	Cardiac MyosinsIBA 11/2011 - 12/2008
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2011 - 11/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Doxazosin (Cardura)FDA LinkGeneric 01/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	CreatinineIBA 01/2018
1	nimesulide (Aulin)IBA 09/2016
1	15-deoxyprostaglandin J2IBA 09/2016
1	Triglycerides (Triacylglycerol)IBA 09/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2016
1	AntistreptolysinIBA 01/2016
1	Fibrinolysin FDA Link 01/2016
1	plasmin receptorIBA 01/2016
1	Phospholipase A2 ReceptorsIBA 01/2016
1	antiglomerular basement membrane antibodyIBA 01/2016
1	UromodulinIBA 08/2015
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2015
1	Verapamil (Calan)FDA LinkGeneric 07/2014
1	azelnidipineIBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2011
1	Etodolac (Lodine)FDA LinkGeneric 02/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2010
1	Cyclooxygenase InhibitorsIBA 02/2010
1	Fenofibrate (CiL)FDA LinkGeneric 11/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2009
1	sodium-iodide symporter (sodium iodide symporter)IBA 02/2009
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 02/2009
1	Thyroglobulin FDA Link 02/2009
1	AutoantigensIBA 02/2009
1	AntibodiesIBA 02/2009
1	UbiquitinIBA 12/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2008
1	Troleandomycin (TAO)FDA Link 11/2008
1	Pain-FreeIBA 11/2008

Therapy/Procedure

6	Therapeutics 11/2022 - 07/2006
2	Transplantation 08/2016 - 02/2013
2	Surgical Amputation (Amputations) 11/2008 - 07/2006
2	Cell Transplantation 11/2008 - 07/2006
1	Renal Dialysis (Hemodialysis) 11/2022
1	Nephrectomy 11/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2008